Upcomers Launches 2.0, Expanding Into Futures With an AI Coach and a Redesigned Experience

Upcomers launched Upcomers 2.0 with expanded simulated trading, adding futures on DXtrade using live CME market data and contract-based position sizing. The platform now supports multiple trading venues (six total platforms including existing CFD markets), plus an upgraded dashboard, competitive leaderboard, and an AI coach that converts activity reviews into next steps. The release signals product expansion for its evaluation programs (already 80,000+ traders and $7M+ paid out since 2024) but is unlikely to move markets broadly.

Analysis

This reads more like a funnel-expansion story than a near-term volume shock for CME. Simulated futures access can widen the top of the trader pipeline, but the economic translation into exchange revenue is delayed and depends on conversion from paper trading to live accounts, higher clearing activity, and sustained retention. In the next 1-3 months, the stock should trade mainly on broader derivatives sentiment rather than this announcement alone.

The incremental winner is CME relative to CFD-centric venues and any platform whose users are searching for a more “professional” derivatives pathway. The second-order benefit is not just more contracts, but more familiarity with micro products and index/commodity workflows, which could support small-lot liquidity and a better retail mix over 6-18 months. That said, the monetization is likely modest unless this kind of offering starts to change actual open interest and contract share, not just simulated engagement.

The contrarian view is that the market may be overestimating the conversion rate. Prop/evaluation firms are high-churn, marketing-driven businesses; if volatility stays subdued or regulators tighten scrutiny around simulated funding models, the user funnel can stall quickly. The thesis is falsified if CME’s retail-relevant volume metrics and open interest fail to improve over the next two quarters, or if options activity continues to outpace futures engagement, implying no meaningful migration into CME-listed products.

Key Decisions for Investors

• No immediate trade in CME; treat this as a watch item and wait for proof in CME volume/open-interest data over the next 1-2 quarters.
• Buy CME on weakness only if the stock sells off with no change in derivatives activity; consider a 3-6 month call spread 5%-15% OTM for a low-premium, asymmetric expression.
• Relative-value idea: long CME vs short CBOE on a basket-neutral basis over 1-3 months if retail futures participation data starts to inflect; this isolates the futures-funnel thesis.
• Falsifier/stop: if CME’s next quarterly report does not show any improvement in exchange volumes or retail-related contract mix, exit the idea.